Variations in the age-specific curves of human papillomavirus prevalence in women worldwide

International Journal of Cancer

Volumn 119, Issue 11, 2006, Pages 2677-2684

  Franceschi, Silvia ^a   Herrero, Rolando ^b   Clifford, Gary M ^a   Snijders, Peter J F ^c   Arslan, Annie ^a   Anh, Pham Thi Hoang ^d,r   Bosch, F Xavier ^e   Ferreccio, Catterina ^f   Hieu, Nguyen Trong ^g   Lazcano Ponce, Eduardo ^h   Matos, Elena ⁱ   Molano, Monica ^j   Qiao, You Lin ^k   Rajkumar, Raj ^l   Ronco, Guglielmo ^m   De Sanjosé, Silvia ^e   Shin, Hai Rim ⁿ   Sukvirach, Sukhon ^o   Thomas, Jaiye O ^p   Meijer, Chris J L M ^c   Munoz, Nubia ^j   Prince, Miguel Angel ^q   Herrera, Lily ^q   Loria, Dora ^q   Luzoro, Amaranta ^q   Ojeda, José Manuel ^q   Prado, Rodrigo ^q   Huang, Ruide ^q   Shao, Shuli ^q   Posso, Hector ^q   Ronderos, Margarita ^q   Dai, Min ^q   Plummer, Martyn ^q   Smith, Jennifer S ^q   Vaccarella, Salvatore ^q   Ghisetti, Valeria ^q   Gillio Tos, Anna ^q   Gallus, Silvano ^q   Segnan, Nereo ^q   Lee, Duk Hee ^q   Hernández Avila, Mauricio ^q   Omigbodun, Akinyinka ^q   Ojemakinde, Kunle ^q   Font, Rebecca ^q   Deechaisate, Apichai ^q   Kesararat, Vitaya ^q   Tunsakul, Sirirat ^q   Yingseri, Pipat ^q   Jacobs, Marcel ^q   more..

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b PROYECTO EPIDEMIOLÓGICO GUANACASTE   (Costa Rica)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d National Cancer Institute   (Viet Nam)

^e CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^f PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^g Hung Vuong Hospital   (Viet Nam)

^h INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

ⁱ UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^j Instituto Nacional de Cancerología   (Colombia)

^k CANCER HOSPITAL   (China)

^l Christian Fellowship Community Health Area   (India)

^m Centro di Riferimento per l'Epidemiologia e la Prevenzione Oncologica   (Italy)

ⁿ National Cancer Center   (South Korea)

^o NATIONAL CANCER INSTITUTE   (Thailand)

^p UNIVERSITY OF IBADAN   (Nigeria)

^q Health Bridge Foundation of Canada ^*

^r Vietnam Office   (Viet Nam)

more..

Author keywords

Age specific curves; Human papillomavirus; Prevalence; Sexual habits

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARGENTINA; ARTICLE; CHILE; CHINA; COLOMBIA; DEVELOPED COUNTRY; FEMALE; GEOGRAPHIC DISTRIBUTION; HUMAN; INDIA; ITALY; KOREA; MAJOR CLINICAL STUDY; MEXICO; NETHERLANDS; NIGERIA; POLYMERASE CHAIN REACTION; POPULATION BIOLOGY; PREVALENCE; PRIORITY JOURNAL; SEXUALITY; SPAIN; THAILAND; UTERINE CERVIX CANCER; VIET NAM; WART VIRUS;

EID: 33750618693     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.22241     Document Type: Article

References (46)

1. Bauer HM, Hildesheim A, Schiffman MH, Glass AG, Rush BB, Scott DR, Cadell DM, Kurman RJ, Manos MM. Determinants of genital human papillomavirus infection in low-risk women in Portland, Oregon. Sex Transm Dis 1993;20:274-8.
2. Giuliano AR, Papenfuss M, Abrahamsen M, Denman C, de Zapien JG, Henze JL, Ortega L, Brown de Galaz EM, Stephan J, Feng J, Baldwin S, Garcia F, et al. Human papillomavirus infection at the United States-Mexico border: implications for cervical cancer prevention and control. Cancer Epidemiol Biomarkers Prev 2001;10: 1129-36.
3. Burk RD, Kelly P, Feldman J, Bromberg J, Vermund SH, DeHovitz JA, Landesman SH. Declining prevalence of cervicovaginal human papillomavirus infection with age is independent of other risk factors. Sex Transm Dis 1996;23:333-41.
4. Kjaer SK, van den Brule AJ, Bock JE, Poll PA, Engholm G, Sherman ME, Walboomers JM, Meijer CJLM. Determinants for genital human papillomavirus (HPV) infection in 1000 randomly chosen young Danish women with normal Pap smear: are there different risk profiles for oncogenic and nononcogenic HPV types? Cancer Epidemiol Biomarkers Prev 1997;6:799-805.
5. Peto J, Gilham C, Deacon J, Taylor C, Evans C, Binns W, Haywood M, Blanko N, Coleman D, Yule R, Desai M. Cervical HPV infection and neoplasia in a large population-based prospective study: the Manchester cohort. Br J Cancer 2004;91:942-53.
6. Winer RL, Lee SK, Hughes JP, Adam DE, Kiviat NB, Koutsky LA. Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students. Am J Epidemiol 2003;157: 218-26.
7. Woodman CB, Collins S, Winter H, Bailey A, Ellis J, Prior P, Yates M, Rollason TP, Young LS. Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study. Lancet 2001;357:1831-6.
8. Hildesheim A, Schiffman MH, Gravitt PE, Glass AG, Greer CE, Zhang T, Scott DR, Rush BB, Lawler P, Sherman M, Kurman RJ, Manos M. Persistence of type-specific human papillomavirus infection among cytologically normal women. J Infect Dis 1994;169:235-40.
9. Herrero R, Hildesheim A, Bratti C, Sherman ME, Hutchinson M, Morales J, Balmaceda I, Greenberg MD, Alfaro M, Burk RD, Wacholder S, Plummer M, et al. Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica. J Natl Cancer Inst 2000;92:464-74.
10. Molano M, Posso H, Weiderpass E, van den Brule AJ, Ronderos M, Franceschi S, Meijer CJLM, Arslan A, Munoz N. Prevalence and determinants of HPV infection among Colombian women with normal cytology. Br J Cancer 2002;87:324-33.
11. Herrero R, Castle PE, Schiffman M, Bratti MC, Hildesheim A, Morales J, Alfaro M, Sherman ME, Wacholder S, Chen S, Rodriguez AC, Burk RD. Epidemiologic profile of type-specific human papillomavirus infection and cervical neoplasia in Guanacaste, Costa Rica. J Infect Dis 2005;191:1796-807.
12. Castle PE, Schiffman M, Herrero R, Hildesheim A, Rodriguez AC, Bratti MC, Sherman ME, Wacholder S, Tarone R, Burk RD. A prospective study of age trends in cervical human papillomavirus acquisition and persistence in Guanacaste, Costa Rica. J Infect Dis 2005;191: 1808-16.
13. Muñoz N, Mendez F, Posso H, Molano M, van den Brule AJ, Ronderos M, Meijer CJLM, Muñoz A; for the Instituto Nacional de Cancerologia HPV Study Group. Incidence, duration, and determinants of cervical human papillomavirus infection in a cohort of Colombian women with normal cytological results. J Infect Dis 2004;190:2077-87.
14. Clifford GM, Gallus S, Herrero R, Muñoz N, Snijders PJF, Vaccarella S, Anh PTH, Ferreccio C, Hieu NT, Matos E, Molano M, Rajkumar R, et al. Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet 2005;366: 991-8.
15. de Sanjosé S, Almirall R, Lloveras B, Font R, Diaz M, Muñoz N, Catala I, Meijer CJLM, Snijders PJF, Herrero R, Bosch FX. Cervical human papillomavirus infection in the female population in Barcelona, Spain. Sex Transm Dis 2003;30:788-93.
16. Matos E, Loria D, Amestoy G, Herrera L, Prince MA, Moreno J, Krunfiy C, van den Brule AJ, Meijer CJLM, Muñoz N, Herrero R, Proyecto Concordia Collaborative Group. Prevalence of human papillomavirus infection among women in Concordia, Argentina: a population-based study. Sex Transm Dis 2003;30:593-9.
17. Ferreccio C, Prado RB, Luzoro AV, Ampuero SL, Snijders PJF, Meijer CJLM, Vaccarella S, Jara AT, Puschel KI, Robles SC, Herrero R, Franceschi S, et al. Population-based prevalence and age distribution of human papillomavirus among women in Santiago, Chile. Cancer Epidemiol Biomarkers Prev 2004;13:2271-6.
18. Lazcano-Ponce E, Herrero R, Muñoz N, Cruz A, Shah KV, Alonso P, Hemández P, Salmeron J, Hemández M. Epidemiology of HPV infection among Mexican women with normal cervical cytology. Int J Cancer 2001;91:412-20.
19. Shin HR, Lee DH, Herrero R, Smith JS, Vaccarella S, Hong SH, Jung KY, Kim HH, Park UD, Cha HS, Park S, Touze A, et al. Prevalence of human papillomavirus infection in women in Busan, South Korea. Int J Cancer 2003;103:413-21.
20. Sukvirach S. Smith JS, Tunsakul S, Muñoz N, Kesararat V, Opasatian O, Chichareon S, Kaenploy V, Ashley R, Meijer CJLM, Snijders PJF, Coursaget P, et al. Population-based human papillomavirus prevalence in Lampang and Songkla, Thailand. J Infect Dis 2003;187: 1246-56.
21. Anh PTH, Hieu NT, Herrero R, Vaccarella S, Smith JS, Thuy NT, Nga NH, Due NB, Ashley R, Snijders PJF, Meijer CJLM, Muñoz N, et al. Human papillomavirus infection among women in South and North Vietnam. Int J Cancer 2003;104:213-20.
22. Dai M, Bao YP, Li N, Clifford GM, Vaccarella S, Snijders PJF, Huang RD, Sun LX, Meijer CJLM, Qiao YL, Franceschi S. Human papillomavirus infection in Shanxi Province, People's Republic of China: a population-based study. Br J Cancer 2006;95:96-101.
23. Franceschi S, Rajkumar R, Snijders PJF, Arslan A, Mahé C, Plummer M, Sankaranarayanan R, Cherian J, Meijer CJLM, Weiderpass E. Papillomavirus infection in rural women in southern India. Br J Cancer 2005;92:601-6.
24. Thomas JO, Herrero R, Omigbodun AA, Ojemakinde K, Ajayi IO, Fawole A, Oladepo O, Smith JS, Arslan A, Muñoz N, Snijders PJF, Meijer CJLM, et al. Prevalence of papillomavirus infection in women in Ibadan, Nigeria: a population-based study. Br J Cancer 2004;90: 638-45.
25. Ronco G, Ghisetti V, Segnan N, Snijders PJF, Gillio-Tos A, Meijer CJLM, Merletti F, Franceschi S. Prevalence of human papillomavirus infection in women in Turin, Italy. Eur J Cancer 2005;41:297-305.
26. Jacobs MV, Walboomers JM, Snijders PJF, Voorhorst FJ, Verheijen RH, Fransen-Daalmeijer N, Meijer CJLM. Distribution of 37 mucosotropic HPV types in women with cytologically normal cervical smears: the age-related patterns for high-risk and low-risk types. Int J Cancer 2000;87:221-7.
27. National Cancer Institute Workshop. The Bethesda System for reporting cervical/vaginal cytologic diagnoses:, revised after the second National Cancer Institute Workshop, April 29-30, 1991. Acta Cytol 1993;37:115-24.
28. van den Brule AJ, Pol R, Fransen-Daalmeijer N, Schouls LM, Meijer CJLM, Snijders PJF. GP5+/6+ PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes. J Clin Microbiol 2002;40:779-87.
29. Gravitt PE, Peyton CL, Apple RJ, Wheeler CM. Genotyping of 27 human papillomavirus types by using L1 consensus PCR products by a single-hybridization, reverse line blot detection method. J Clin Microbiol l998;36:3020-7.
30. Qu WM, Jiang G, Cruz Y, Chang CJ, Ho GYF, Klein RS, Burk RD. PCR detection of human papillomavirus: comparison between MY09/MY11 and GP5+/GP6+ primer systems. J Clin Microbiol 1997;35:1304-10.
31. Muñoz N, Bosch FX, de Sanjosé S, Herrero R, Castellsagué X, Shah KV, Snijders PJF, Meijer CJLM. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003;348:518-27.
32. Doll R, Payne P, Waterhouse J. Cancer incidence in five continents: a technical report (for UICC). Berlin: Springer-Verlag, 1966.
33. Shin HR, Franceschi S, Vaccarella S, Roh JW, Ju YH, Oh JK, Kong HJ, Rha SH, Jung SI, Kim JI, Jung KY, van Doom LJ, et al. Prevalence and determinants of genital infection with papillomavirus, in female and male university students in Busan, South Korea. J Infect Dis 2004;190:468-76.
34. Yang L, Huangpu XM, Zhang SW, Lu FZ, Sun XD, Sun J, Mu R, Li LD, Qiao YL. [Changes of mortality rate for cervical cancer during 1970's and 1990's periods in China]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 2003;25:386-90.
35. Ferlay J, Bray F, Pisani P, Parkin DM. Globocan 2000: incidence, mortality and prevalence worldwide [cd-rom], Lyon: International Agency for Research on Cancer, 2001.
36. Belinson J, Qiao YL, Pretorius R, Zhang WH, Elson P, Li L, Pan QJ, Fischer C, Lorincz A, Zahniser D. Shanxi Province Cervical Cancer Screening Study: a cross-sectional comparative trial of multiple techniques to detect cervical neoplasia. Gynecol Oncol 2001;83:439-44.
37. Sankaranarayanan R, Nene BM, Dinshaw KA, Mahe C, Jayant K, Shastri SS, Malvi SG, Chinoy R, Kelkar R, Budukh AM, Keskar V, Rajeshwarker R, et al. A cluster randomized controlled trial of visual, cytology and human papillomavirus screening for cancer of the cervix in rural India. Int J Cancer 2005;116:617-23.
38. Clifford GM, Franceschi S. HPV in sub-Saharan Africa (editorial). Papillomavirus Rep 2005;16:322-6.
39. Palefsky JM, Minkoff H, Kalish LA, Levine A, Sacks HS, Garcia P, Young M, Melnick S, Miotti P, Burk R. Cervicovaginal human papillomavirus infection in human immunodeficiency virus-1 (HIV)-positive and high-risk HIV-negative women. J Natl Cancer Inst 1999;91: 226-36.
40. Mayaud P, Gill DK, Weiss HA, Uledi E, Kopwe L, Todd J, ka-Gina G, Grosskurth H, Hayes RJ, Mabey DC, Lacey CJ. The interrelation of HIV, cervical human papillomavirus, and neoplasia among antenatal clinic attenders in Tanzania. Sex Transm Infect 2001;77:248-54.
41. Winer RL, Koutsky LA. Human papillomavirus through the ages. J Infect Dis 2005;191:1787-9.
42. Moscicki AB, Shiboski S, Broering J, Powell K, Clayton L, Jay N, Darragh TM, Brescia R, Kanowitz S, Miller SB, Stone J, Hanson E, et al. The natural history of human papillomavirus infection as measured by repeated DNA testing in adolescent and young women. J Pediatr 1998;132:277-84.
43. IARC.IARC handbooks of cancer prevention, vol. 10: Cervix cancer screening. Lyon: IARC Press, 2005.
44. Vaccarella S, Franceschi S, Herrero R, Muñoz N, Snijders PJF, Clifford GM, Smith JS, Lazcano-Ponce E, Sukvirach S, Shin HR. de Sanjosé S, Molano M, et al. Sexual behaviour, condom use and HPV: pooled analysis of the International Agency for Research on Cancer HPV Prevalence Surveys. Cancer Epidemiol Biomarkers Prev 2006;15:326-33.
45. Laukkanen P, Koskela P, Pukkala E, Dillner J, Läärä E, Knekt P, Lehtinen M. Time trends in incidence and prevalence of human papillomavirus type 6, 11 and 16 infections in Finland. J Gen Virol 2003; 84:2105-9.
46. Peto J, Gilham C, Deacon J, Taylor C, Evans C, Binns W, Haywood M, Elanko N, Coleman D, Yule R, Desai M. Cervical HPV infection and neoplasia in a large population-based prospective study: the Manchester cohort. Br J Cancer 2004;91:942-53.